Status:
COMPLETED
Pregabalin for Alcohol Dependence
Lead Sponsor:
St. Petersburg Bekhterev Research Psychoneurological Institute
Collaborating Sponsors:
St.-Petersburg Bekhterev Research Psychoneurological Institute, Russian Federation
Conditions:
Alcoholism
Eligibility:
All Genders
20-60 years
Phase:
PHASE4
Brief Summary
The study hypothesis is: Pregabalin is superior to placebo in preventing relapse to drinking and reducing drinking severity
Detailed Description
This is a two cell double blind placebo controlled randomized clinical trial of pregabalin for alcohol dependence
Eligibility Criteria
Inclusion
- Alcohol Dependence by ICD-X criteria
Exclusion
- Severe co-morbid psychiatric and somatic diseases
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02205879
Start Date
January 1 2013
End Date
December 1 2019
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St.-Petersburg Bekhterev Reserach Psychoneurological Institute
Saint Petersburg, Russia, 192019